Intellia Therapeutics, Inc. (NTLA)
13.14
-0.68
(-4.88%)
USD |
NASDAQ |
Mar 05, 16:00
13.19
+0.04
(+0.34%)
After-Hours: 19:48
Intellia Therapeutics Cash from Investing (Quarterly) : 27.53M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 108.41M |
| Personalis, Inc. | -14.38M |
| Recursion Pharmaceuticals, Inc. | -1.244M |
| Pacific Biosciences of California, Inc. | 26.03M |
| Twist Bioscience Corp. | -9.933M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -69.28M |
| Cash from Financing (Quarterly) | 1.977M |
| Free Cash Flow | -395.86M |
| Free Cash Flow Per Share (Quarterly) | -0.5988 |
| Free Cash Flow to Equity (Quarterly) | -64.77M |
| Free Cash Flow to Firm (Quarterly) | -69.41M |
| Free Cash Flow Yield | -27.80% |